Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| InspireMD, Inc.NSPR · Entity 7318 | Director | September 21, 2026 | September 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
InspireMD, Inc.
Report date September 21, 2026 · Filed September 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series J Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.38 | Direct | 15,312 |
Reported balance
After 2026-09-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-18 · Other · Disposed 15,313 · Balance 15,312 F1: See Exhibit 99.1; Note 1 F2: See Exhibit 99.1; Note 2 |
| Series J Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.77 | Direct | 15,313 |
Reported balance
After 2026-09-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-18 · Other · Acquired 15,313 · Balance 15,313 F1: See Exhibit 99.1; Note 1 F3: See Exhibit 99.1; Note 3 |
| Series K Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.38 | Direct | 0 |
Reported balance
After 2026-09-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-18 · Other · Disposed 30,624 · Balance 0 F4: See Exhibit 99.1; Note 4 F5: See Exhibit 99.1; Note 5 |
| Series K Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.77 | Direct | 30,624 |
Reported balance
After 2026-09-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-18 · Other · Acquired 30,624 · Balance 30,624 F4: See Exhibit 99.1; Note 4 F6: See Exhibit 99.1; Note 6 |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1; Note 1
F2: See Exhibit 99.1; Note 2
F3: See Exhibit 99.1; Note 3
F4: See Exhibit 99.1; Note 4
F5: See Exhibit 99.1; Note 5
F6: See Exhibit 99.1; Note 6
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 18, 2026 Filed Sep 23, 2026 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries K Warrant (right to buy) · Derivative | 30,624 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001493152-26-043911 · ownership.xml · derivative · entry 4 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,624 Underlying: Common Stock · 30,624 shares Expires not disclosed F4 · kind: See Exhibit 99.1; Note 4 F6 · derivative.expiration_date: See Exhibit 99.1; Note 6 Read SEC document |
| September 18, 2026 Filed Sep 23, 2026 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries K Warrant (right to buy) · Derivative | 30,624 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-26-043911 · ownership.xml · derivative · entry 3 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,624 shares Expires not disclosed F4 · kind: See Exhibit 99.1; Note 4 F5 · derivative.expiration_date: See Exhibit 99.1; Note 5 Read SEC document |
| September 18, 2026 Filed Sep 23, 2026 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries J Warrant (right to buy) · Derivative | 15,313 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001493152-26-043911 · ownership.xml · derivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,313 Underlying: Common Stock · 15,313 shares Expires not disclosed F1 · kind: See Exhibit 99.1; Note 1 F3 · derivative.expiration_date: See Exhibit 99.1; Note 3 Read SEC document |
| September 18, 2026 Filed Sep 23, 2026 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries J Warrant (right to buy) · Derivative | 15,313 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-26-043911 · ownership.xml · derivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,312 Underlying: Common Stock · 15,313 shares Expires not disclosed F1 · kind: See Exhibit 99.1; Note 1 F2 · derivative.expiration_date: See Exhibit 99.1; Note 2 Read SEC document |
| May 07, 2026 Filed May 8, 2026 21:03 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 90,000 | $1.18 | $106,200.00 |
DisclosureSEC source: 0001493152-26-022013 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 834,478 F1 · price: The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.15 to $1.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 23:10 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 88,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-002667 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 744,478 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 48,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-017587 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 656,425 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on October 7, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 21:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 41,322 | $2.42 | $99,999.24 |
DisclosureSEC source: 0001641172-25-021934 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 608,425 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). F2 · price: The purchase price per share of common stock in the Private Placement was $2.42. Read SEC document |
| June 25, 2025 Filed Jul 23, 2025 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries I Warrant (right to buy) · Derivative | 30,624 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001641172-25-020692 · ownership.xml · derivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,624 shares Expires 2025-07-23 Read SEC document |
| June 25, 2025 Filed Jul 23, 2025 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherCommon Stock | 30,624 | $1.38 | $42,343.80 |
DisclosureSEC source: 0001641172-25-020692 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 567,103 Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 14,836 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001729 · ownership.xml · derivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,743 Underlying: Common Stock · 14,836 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 32,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001729 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 534,279 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 7, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:20 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries H Warrant (right to buy) · Derivative | 30,625 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-24-022012 · ownership.xml · derivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,625 shares Expires 2024-06-26 Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:20 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherCommon Stock | 30,625 | $1.38 | $42,345.19 |
DisclosureSEC source: 0001493152-24-022012 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,788 Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:52 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 11,098 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001493152-24-003771 · ownership.xml · derivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,907 Underlying: Common Stock · 11,098 shares Expires 2034-01-23 F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:52 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 29,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-003771 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 471,163 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 23, 2025 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| January 02, 2024 Filed Jan 11, 2024 21:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 3,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-002065 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 442,131 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended December 31, 2023. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 50,000 | $2.53 | $126,540.00 |
DisclosureSEC source: 0001493152-23-043561 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 438,902 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.47 to $2.60, inclusive. The Reporting Person undertakes to provide to InspireMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 2,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-035640 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,902 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended September 30, 2023. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:38 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 3,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-023455 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,250 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended June 30, 2023. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 49,750 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001493152-23-018331 · ownership.xml · derivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,809 Underlying: Common Stock · 49,750 shares Expires 2033-05-17 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 149,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-018331 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 382,805 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseSeries K Warrants to purchase Common Stock · Derivative | 30,624 | $1.63 Strike: $1.38 | $49,999.80 |
DisclosureSEC source: 0001493152-23-017787 · ownership.xml · derivative · entry 5 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,624 Underlying: Common Stock · 30,624 shares Expires not disclosed F9 · shares: The aggregate number of warrants reported in this row consists of 30,624 Series K Warrants that were acquired in the Private Placement. F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F10 · derivative.expiration_date: The Series K Warrants have a term of the earlier of (i) May 15, 2028 and (ii) 20 trading days following the end of the fourth fiscal quarter after the fiscal quarter in which the first commercial sales of the CGuard Carotid Stent System in the United States begin. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseSeries J Warrants to purchase Common Stock · Derivative | 30,625 | $1.63 Strike: $1.38 | $50,001.44 |
DisclosureSEC source: 0001493152-23-017787 · ownership.xml · derivative · entry 4 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,625 Underlying: Common Stock · 30,625 shares Expires not disclosed F7 · shares: The aggregate number of warrants reported in this row consists of 30,625 Series J Warrants that were acquired in the Private Placement. F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F8 · derivative.expiration_date: The Series J Warrants have a term of the earlier of (i) May 15, 2028 and (ii) 20 trading days following the Company's announcement of receipt of FDA approval for the SwitchGuard transcarotid system and CGuard Prime 80 cm. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseSeries I Warrants to purchase Common Stock · Derivative | 30,624 | $1.63 Strike: $1.38 | $49,999.80 |
DisclosureSEC source: 0001493152-23-017787 · ownership.xml · derivative · entry 3 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,624 Underlying: Common Stock · 30,624 shares Expires not disclosed F5 · shares: The aggregate number of warrants reported in this row consists of 30,624 Series I Warrants that were acquired in the Private Placement. F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F6 · derivative.expiration_date: The Series I Warrants have a term of the earlier of (i) May 15, 2028 and (ii) 20 trading days following the Company's announcement of receipt of Premarket Approval (PMA) from the Food and Drug Administration ("FDA") for the CGuard Prime Carotid Stent System (135 cm). Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseSeries H Warrants to purchase Common Stock · Derivative | 30,625 | $1.63 Strike: $1.38 | $50,001.44 |
DisclosureSEC source: 0001493152-23-017787 · ownership.xml · derivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,625 Underlying: Common Stock · 30,625 shares Expires not disclosed F3 · shares: The aggregate number of warrants reported in this row consists of 30,625 Series H Warrants that were acquired in the Private Placement. F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F4 · derivative.expiration_date: The Series H Warrants have a term of the earlier of (i) May 15, 2028 and (ii) 20 trading days following the Company's public release of primary and secondary end points related to one year follow up study results from the Company's C-Guardians pivotal trial. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 61,249 | $1.63 | $100,001.24 |
DisclosureSEC source: 0001493152-23-017787 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,545 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on May 12, 2023 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 21:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 8,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-010853 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,296 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended March 31, 2023. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 20:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 35,500 | $1.91 | $67,769.50 |
DisclosureSEC source: 0001493152-22-023735 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,194 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.96 to $1.72, inclusive. The Reporting Person undertakes to provide to InspireMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 14:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 16,393 | $3.08 | $50,436.34 |
DisclosureSEC source: 0001493152-21-032757 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,694 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.09 to $3.05, inclusive. The Reporting Person undertakes to provide to InspireMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| November 17, 2021 Filed Nov 18, 2021 21:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 290 | $3.77 | $1,093.30 |
DisclosureSEC source: 0001493152-21-029222 · ownership.xml · nonDerivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,301 Read SEC document |
| November 17, 2021 Filed Nov 18, 2021 21:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 25,640 | $3.86 | $98,867.84 |
DisclosureSEC source: 0001493152-21-029222 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,011 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.90 to $3.77, inclusive. The Reporting Person undertakes to provide to InspireMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| October 13, 2021 Filed Oct 14, 2021 21:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 5,749 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001493152-21-025452 · ownership.xml · derivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,749 Underlying: Common Stock · 5,749 shares Expires 2031-10-13 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024 subject to the Reporting Person's continued service. Read SEC document |
| October 13, 2021 Filed Oct 14, 2021 21:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 17,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-025452 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,371 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 21:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 22,249 | $4.19 | $93,245.56 |
DisclosureSEC source: 0001493152-21-021349 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,123 F1 · balance_after: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.219 to $4.085, inclusive. The Reporting Person undertakes to provide to InspireMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). F3 · balance_after: All share amounts reflect the Company's reverse stock split effectuated on April 26, 2021. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 10:20 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOption to Purchase Common Stock · Derivative | 75,000 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001493152-21-009317 · ownership.xml · derivative · entry 3 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,650 Underlying: Common Stock · 75,000 shares Expires 2031-04-19 F2 · derivative.exercise_date: These options vest and become exercisable in three equal installments, with 1/3 vesting on each of April 19, 2022, April 19, 2023 and April 19, 2024, subject to the Reporting Person's continued service. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 12:11 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseWarrants · Derivative | 120,965 | $0.62 Strike: $0.68 | $74,998.30 |
DisclosureSEC source: 0001493152-21-003204 · ownership.xml · derivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,188 Underlying: Common Stock · 120,965 shares Expires 2026-02-08 F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 241,930 shares of common stock and warrants to purchase 120,965 shares of common stock together, as part of 241,930 units, at a purchase price of $0.62 per unit. F1 · derivative.underlying_shares: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 241,930 shares of common stock and warrants to purchase 120,965 shares of common stock together, as part of 241,930 units, at a purchase price of $0.62 per unit. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 12:11 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 241,930 | $0.62 | $149,996.60 |
DisclosureSEC source: 0001493152-21-003204 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703,103 F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 241,930 shares of common stock and warrants to purchase 120,965 shares of common stock together, as part of 241,930 units, at a purchase price of $0.62 per unit. F1 · balance_after: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 241,930 shares of common stock and warrants to purchase 120,965 shares of common stock together, as part of 241,930 units, at a purchase price of $0.62 per unit. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 14:18 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseWarrants · Derivative | 222,223 | $0.45 Strike: $0.50 | $100,000.35 |
DisclosureSEC source: 0001493152-20-019601 · ownership.xml · derivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,223 Underlying: Common Stock · 222,223 shares Expires 2025-10-16 F1 · derivative.underlying_shares: The Reporting Person purchased, in a private placement transaction, 222,223 shares of common stock and 222,223 warrants to purchase common stock together, as part of 222,223 units, at a purchase price of $0.45 per unit. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 14:18 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 222,223 | $0.45 | $100,000.35 |
DisclosureSEC source: 0001493152-20-019601 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,173 F1 · shares: The Reporting Person purchased, in a private placement transaction, 222,223 shares of common stock and 222,223 warrants to purchase common stock together, as part of 222,223 units, at a purchase price of $0.45 per unit. F2 · balance_after: 238,950 of these shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 12, 2021, October 12, 2022 and October 12, 2023, subject to the Reporting Person's continued service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.